#AstraZeneca is likely to run an additional global #trial to assess the efficacy of its #Covid-19 #vaccine using a lower dosage, its chief executive was quoted as saying on Thursday amid questions over the results of its late-stage study.
AstraZeneca Covid-19 vaccine: Company to run new tests amid fresh doubts







